Abstract
BackgroundMitochondrial respiratory chain disorders are the most prevalent group of inherited neurometabolic diseases. Treatment is supportive, although some treatments report disease-modifying efficacy in isolated cases and small trials. This review...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Neurology, Neurosurgery & Psychiatry
Paper Title
Journal
Date
